Lupin: The Antara Story
  • Prabha Hedge
  • Jan 17 2014

January 17: Like most pharmaceutical companies, Lupin gets a bulk of its revenue from U.S.A. But, unlike its peers the company bet on the branded segment, which gave it better margins and guaranteed incomes. In an exclusive conversation with Mini Menon, Nilesh Gupta, MD, Lupin, speaks about acquiring Antara and how it helped the company scale up its margins.